Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Mais filtros











Base de dados
Intervalo de ano de publicação
1.
PLoS Negl Trop Dis ; 5(1): e930, 2011 Jan 04.
Artigo em Inglês | MEDLINE | ID: mdl-21245915

RESUMO

Immunologically intact BALB/c mice infected with Leishmania mexicana develop non-healing progressively growing lesions associated with a biased Th2 response while similarly infected IL-4Rα-deficient mice fail to develop lesions and develop a robust Th1 response. In order to determine the functional target(s) for IL-4/IL-13 inducing non-healing disease, the course of L. mexicana infection was monitored in mice lacking IL-4Rα expression in specific cellular compartments. A deficiency of IL-4Rα expression on macrophages/neutrophils (in LysM(cre)IL-4Rα(-/lox) animals) had minimal effect on the outcome of L. mexicana infection compared with control (IL-4Rα(-/flox)) mice. In contrast, CD4(+) T cell specific (Lck(cre)IL-4Rα(-/lox)) IL-4Rα(-/-) mice infected with L. mexicana developed small lesions, which subsequently healed in female mice, but persisted in adult male mice. While a strong Th1 response was manifest in both male and female CD4(+) T cell specific IL-4Rα(-/-) mice infected with L. mexicana, induction of IL-4 was manifest in males but not females, independently of CD4(+) T cell IL-4 responsiveness. Similar results were obtained using pan-T cell specific (iLck(cre)IL-4Rα(-/lox)) IL-4Rα(-/-) mice. Collectively these data demonstrate that upon infection with L. mexicana, initial lesion growth in BALB/c mice is dependent on non-T cell population(s) responsive to IL-4/IL-13 while progressive infection is dependent on CD4(+) T cells responsive to IL-4.


Assuntos
Linfócitos T CD4-Positivos/imunologia , Leishmania mexicana/imunologia , Leishmaniose Cutânea/imunologia , Leishmaniose Cutânea/mortalidade , Receptores de Superfície Celular/deficiência , Receptores de Superfície Celular/imunologia , Animais , Feminino , Interleucina-13/imunologia , Interleucina-4/imunologia , Leishmania mexicana/patogenicidade , Masculino , Camundongos , Camundongos Endogâmicos BALB C , Camundongos Knockout , Fatores Sexuais
2.
Infect Immun ; 77(7): 2971-8, 2009 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-19433541

RESUMO

Leishmania mexicana cysteine peptidases (CPs) have been identified as important parasite virulence factors. More recently, a natural inhibitor of CPs (ICP) from L. mexicana has been characterized, and ICP mutants have been created. Infection of BALB/c mice with ICP null mutants or ICP reexpressing mutants resulted in nonhealing, progressively growing lesions albeit slightly attenuated compared with the growth of lesions produced by wild-type parasites. In contrast, BALB/c mice infected with mutants overexpressing ICP were able to significantly control lesion growth or heal. While BALB/c mice infected with wild-type parasites, ICP null mutants, or ICP reexpressing mutants produced significant antibody responses, including immunoglobulin E (IgE), no Th1 response, as indicated by antigen-induced splenocyte gamma interferon (IFN-gamma) production, could be demonstrated. In contrast, BALB/c mice infected with mutants overexpressing ICP produced significantly less antibody, particularly IgE, as well as significantly reduced splenocyte interleukin-4 and enhanced IFN-gamma production. BALB/c mice were able to resolve infection following infection with one ICP overexpressing clone, which was subsequently used for vaccination studies with BALB/c mice. However, no protection was afforded these mice when they were challenged with wild-type parasites. Nevertheless, two other mouse strains susceptible to L. mexicana, C3H and C57BL/6, vaccinated with overexpressing ICP mutants were able to control challenge infection associated with an enhanced Th1 response. This study confirms that L. mexicana CPs are virulence factors and that ICPs have therapeutic potential.


Assuntos
Cisteína Endopeptidases/metabolismo , Inibidores de Cisteína Proteinase/biossíntese , Leishmania mexicana/imunologia , Leishmania mexicana/patogenicidade , Leishmaniose Cutânea/patologia , Células Th1/imunologia , Fatores de Virulência/antagonistas & inibidores , Animais , Anticorpos Antiprotozoários/sangue , Inibidores de Cisteína Proteinase/genética , Feminino , Deleção de Genes , Teste de Complementação Genética , Imunoglobulina E/sangue , Interferon gama/metabolismo , Leishmaniose Cutânea/imunologia , Camundongos , Camundongos Endogâmicos BALB C , Camundongos Endogâmicos C3H , Camundongos Endogâmicos C57BL , Índice de Gravidade de Doença , Baço/imunologia , Virulência
3.
Microbes Infect ; 10(7): 834-9, 2008 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-18538609

RESUMO

Interleukin-18 deficient mice on a BALB/c background display increased resistance to cutaneous infection with Leishmania mexicana, with reduced lesion progression and reduced parasite burdens compared with wild-type mice. Infected IL-18-/- mice had lower antigen specific IgG1 levels and total IgE levels and conversely higher antigen specific IgG2a levels than similarly infected wild-type mice. Splenocytes isolated from infected IL-18-/- mice produced significantly lower levels of antigen induced IL-4 and higher levels of IFN-gamma than wild-type animals. Consequently IL-18 during L. mexicana infection of BALB/c mice promotes a Th2 biased response and thereby has a disease exacerbating role.


Assuntos
Interleucina-18/imunologia , Leishmania mexicana/imunologia , Células Th2/imunologia , Animais , Anticorpos Antiprotozoários/sangue , Imunoglobulina E/sangue , Imunoglobulina G/sangue , Interferon gama/metabolismo , Interleucina-18/deficiência , Interleucina-4/metabolismo , Linfócitos/imunologia , Camundongos , Camundongos Endogâmicos BALB C , Camundongos Knockout , Índice de Gravidade de Doença , Pele/patologia , Baço/imunologia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA